Company: VREOF
Filing Date: 2025-03-11
Form Type: PREM14C
Source: 0001140361-25-008065
Chunk: 245

Company: Vireo Growth Inc.
Filing Date: 2025-03-11
Form: PREM14C
Chunk 245
---
 are determined to be classified as a liability and/or an asset on the balance sheet, then Vireo would recognize subsequent changes in the fair value of such items as a gain or loss at each reporting period during the Wholesome Earn-Out Period, pursuant to the provisions of ASC Topic 815, Derivatives and Hedging .

Identifiable Net Assets Acquired

In connection with the Wholesome Merger, the Company will recognize $56,467,591 of additional acquired intangible assets and goodwill, which represents the excess purchase price over fair value of identifiable net assets acquired, pursuant to the preliminary purchase price allocation. Goodwill will not be amortized, but instead will be tested for impairment at least annually or more frequently if certain indicators are present. In the event that the value of goodwill or other intangible assets become impaired in the future, an accounting charge for impairment would be recognized during the period in which the determination was made.

The purchase price has been allocated to the tangible and identifiable intangible assets and liabilities based on the respective estimated fair values and will be finalized upon the closing of the Wholesome Merger. The excess of the

<div align='center'>141</div>

TABLE OF CONTENTS

purchase price over the net tangible and identifiable intangible assets has been recorded as goodwill. Goodwill represents potential revenue synergies related to new product development, various expense synergies and opportunities to enter new markets, and is assigned to the Company’s cultivation, production, and sale of cannabis business segment. Note 5. Net Loss per Share Net loss per share was calculated using the historical weighted average shares outstanding and the issuance of additional shares in connection with the Wholesome Merger, assuming the shares were outstanding since January 1, 2024. As the Wholesome Merger is being reflected as if it had occurred at the beginning of the period presented, the calculation of weighted average shares outstanding for basic and diluted net loss per share assumes that the shares issuable relating to the Wholesome Merger have been outstanding for the entirety of the period presented.

|                                                            |     |   For the Year Ended 
 December 31, 2024(1) |
| Numerator:                                                 |     |                      |
| Pro forma net loss attributable to common shareholders     |     |        $(22,610,966) |
| Denominator:                                               |     |                      |
| Weighted average shares outstanding – basic and diluted(2) |     |          310,938,604 |
| Net loss per